Company / Financials
KYNTRA BIO, INC. Financials
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$29.6M
FY2025 · -36.7% YoY
Net Income
-$47.6M
FY2025 · +83.3% YoY
Profit Margin
-160.6%
FY2025 · net income / revenue
ROE
-
FY2025 · return on equity
Total Assets
$119.6M
FY2025
Total Debt
$75.0M
-2.50x debt/equity
Equity
-$30.0M
FY2025
ROA
-39.8%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -3.33 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$29.6M-36.7% YoYNet Income HistoryProfit after all expenses and taxes-$47.6M+83.3% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$15.6M+292.8% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$150.4M+53.4% YoYSG&A Expense HistorySelling, general, and administrative expenses$49.3M-43.0% YoYR&D Expense HistoryResearch and development spending$95.7M-64.1% YoYInterest Expense HistoryCost of borrowing and debt obligations$8.2M+1.9% YoYIncome Tax HistoryTotal income tax expense-$269.0K-6.7% YoYEPS (Basic) HistoryBasic earnings per share-$11.89-307.2% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$11.89-307.2% YoY